John Neylan

John Neylan

Directeur Technique/Scientifique/R&D chez AKARI THERAPEUTICS, PLC
72 ans
Health Technology
Consumer Services
Commercial Services

Profil

John F.
Neylan
is Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc since 2022.
Formerly, Dr. Neylan was Chief Medical Officer & Senior Vice President at Angion Biomedica Corp.
from 2018 to 2022, Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018, Vice President-Research & Development at Wyeth Research from 2000 to 2008, Director at Advances In Kidney Disease & Health, Senior Vice President-Clinical Development at Genzyme Corp., Professor at Emory University, Assistant Professor at the University of California, Davis, and President of The American Society of Transplantation.
Education includes undergraduate studies at Duke University and a doctorate from Rush Medical College.

Postes actifs de John Neylan

SociétésPosteDébut
AKARI THERAPEUTICS, PLC Directeur Technique/Scientifique/R&D 08/11/2022

Anciens postes connus de John Neylan

SociétésPosteFin
ANGN BIOM Directeur Technique/Scientifique/R&D 15/08/2022
KERYX BIOPHARMACEUTICALS Directeur Technique/Scientifique/R&D 12/12/2018
Corporate Officer/Principal 01/05/2008
Directeur/Membre du Conseil -
President -
Voir l'expérience en détail de John Neylan

Formation de John Neylan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

56

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. John Neylan
🔇